Moreover, some studies have demonstrated that intra-tumoral injections of LL-37 stimulate the innate immune system by acting plasmacytoid dendritic cells, which can in turn mediate tumor destruction (Dolkar et al., 2018). This evidence concerns the gene CAMP and neoplasm.